PTK2B and prostate cancer: The reactive oxygen species (ROS) inducer eicosapentaenoic acid (EPA), which dephosphorylates PyK2, exhibited anti-cancer effects by decreasing the proliferation and migration of PC3 prostate cancer cells [93].